Biopôle’s Start-Up Fund aims to promote early access to innovation in life sciences


Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sciences entrepreneurs.

With the creation of the Biopôle Start-up Fund, Biopôle confirms its eagerness to support life sciences entrepreneurs and give them firm foundations in the canton of Vaud.
In 2018, the campus launched StartLab, the first incubator of its kind for life sciences start-ups in Switzerland. In 2019, it created the Digital Health Hub, where companies striving to develop digital solutions can work together and share experiences.
The new Biopôle Start-Up Fund, with an annual budget of approximately CHF 500’000, aims to help accelerate the innovation of start-ups established at Biopôle and active in any area of the life sciences, be it biotech, medtech, pharma, digital health, nutrition or any other related field.
The initiative is intended to support projects that promote the life sciences in their initial innovation phase. Applications are welcomed at any time from start-ups that are established at Biopôle, have been in existence for less than 5 years and have raised less than CHF 5 million in funding.
Biopôle’s management team will be supported by an independent Scientific Advisory Board in evaluating and selecting the best and most promising applications, taking into account scientific excellence, the relevance of the business model and the quality of the founding and management teams.
No strings attached financing for promising start-ups
Nasri Nahas, CEO of Biopôle, explains that the fund’s primary goal is to encourage start-ups that show scientific impact and growth potential : “We at Biopôle are always eager to help our entrepreneurs in their innovation journey. With this new fund, we aspire to help our most promising start-ups to focus on their scientific contributions and on serving their clients and stakeholders. That is also why we have devised our Start-up Fund not as equity investment or a traditional loan but as a source of no-strings-attached financing. Only the most successful companies will be asked to reimburse their funding to help give back to the Biopôle community.

More Stories about Greater Geneva Bern area

HubsGoGlobal is a platform under the PharmaBoardroom brand that focuses on the competitive advantages of the Hub and its value proposition in terms of strategic, operational, financial, talent and lifestyle aspects.

PharmaBoardroom provides industry trends, news and reports from all over the world. This site is for senior professionals who want to understand local and global markets.


Greater Geneva Bern area is an initiative of the cantons of
Bern, Fribourg, Vaud, Neuchâtel, Geneva and Valais.

World Trade Center – Av. de Gratta-Paille 2
PO Box 252
1000 Lausanne 22 – Switzerland


Copyright: All rights reserved. No part of this site maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this website, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors.

2021 © PharmaBoardroom